Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Privium Fund Management B.V. Boosts Stake in Biogen Inc. $BIIB
03:22am, Saturday, 31'st Jan 2026
Privium Fund Management B.V. raised its stake in shares of Biogen Inc. (NASDAQ: BIIB) by 153.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund
Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
11:01am, Friday, 30'th Jan 2026
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status
09:56am, Thursday, 29'th Jan 2026
BIIB secures FDA's Breakthrough Therapy status for litifilimab in cutaneous lupus, backed by phase II results, while advancing phase III and broader lupus studies.
Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous lupus erythematosus (CLE) skin disease activity Litifi
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti
Biogen Inc. $BIIB Stock Holdings Lowered by Campbell & CO Investment Adviser LLC
03:14am, Saturday, 24'th Jan 2026
Campbell and CO Investment Adviser LLC cut its position in Biogen Inc. (NASDAQ: BIIB) by 69.0% during the undefined quarter, according to the company in its most recent filing with the Securities and
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026
08:29am, Tuesday, 20'th Jan 2026
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk.
Market Today: Chips, energy and housing lead -- TSM, MU, NVO in focus
05:35pm, Friday, 16'th Jan 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in MBUU by 2.48%Stock News Stocks end flat as chips rally: Taiwan Semiconductor (TSM) and
Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy
08:48am, Tuesday, 13'th Jan 2026
Biogen CEO Chris Viehbacher joins 'Squawk Box' to discuss the company's 2026 outlook, drug pipeline, the focus on rare diseases, state of the biotech sector, and more.
Biogen Inc. (BIIB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
07:45pm, Monday, 12'th Jan 2026
Biogen Inc. (BIIB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
11:05am, Monday, 12'th Jan 2026
CAMBRIDGE, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose regimen of SPINRAZA® (n
Elixir begins mobilisation for Lorelle-3 as spud nears
05:16am, Monday, 12'th Jan 2026
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) says mobilisation of the Helmerich & Payne (H&P) FlexRig 3 (Rig 648) has started, with the unit moving from Brisbane...
Tamboran appoints Todd Abbott as CEO effective January 15
05:14am, Monday, 12'th Jan 2026
Tamboran Resources Corporation (ASX:TBN, NYSE:TBN, OTC:TBNRL) has appointed Todd Abbott as its new chief executive officer, effective January 15, 2026, as...
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and h
Cerity Partners LLC Increases Position in Biogen Inc. $BIIB
03:32am, Sunday, 11'th Jan 2026
Cerity Partners LLC raised its position in shares of Biogen Inc. (NASDAQ: BIIB) by 76.7% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchan
